Books
Emergencies in Gastroenterology
And Hepatology
An easily accessible guide to diagnosing and managing critical situations, Emergencies in Gastroenterology and Hepatology aids doctors in dealing with acutely sick patients quickly and effectively. The book provides practical advice on how to make difficult decisions in an emergency situation. Areas covered include life and death emergencies, as well as the broad problems faced by on-call Gastroenterologists and Hepatologists on a daily basis. The focus throughout is on immediate management, but the book also includes reference to long term follow up for certain problems.
Each chapter has an associated algorithm, which summarises the contents of the chapter, providing an aide memoir for the reader and facilitating learning, as well as being a quick reference tool. Bullet-point information for speed and clarity combined with the integral cross-referencing system, further enables quick access to the necessary information.
Oxford Desk
Reference
Acute Medicine
In this era of evidence-based medicine, one of the biggest challenges confronting acute medicine clinicians is keeping abreast with the rapidly changing recommendations that guide clinical practice. Oxford Desk Reference: Acute Medicine allows easy access to evidence-based materials on commonly encountered acute medical problems to ensure the optimum management of the acutely unwell patient. Collating all the research-based guidelines and protocols in one easily accessible place and presenting it in a uniform style, this practical book is hugely advantageous for a busy clinician as it is not always easy to access research-based guidelines and protocols when needed in the clinic. The book is designed so that each subject forms a self-contained topic in its own right. This makes the information simple to find, read, and absorb, so that the book can be consulted in the clinic or ward setting for information on the optimum management of a particular condition. Edited by three experts in acute medicine, this book should never be far from the acute medicine clinician’s side.
Papers
- HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn’s Disease.
Sazonovs A, Kennedy NA, Moutsianas L, Heap GA, Rice DL, Reppell M, Bewshea CM, Chanchlani N, WalkerGJ, Perry MH, McDonald TJ, Lees CW, Cummings JRF, Parkes M, Mansfield JC, Irving PM, Barrett JC, McGovern D, Goodhand JR, Anderson CA, Ahmad T; PANTS Consortium. Gastroenterology. 2020 Jan;158(1):189-199. - British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.
Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, Hayee B, Lomer MCE, Parkes GC, Selinger C, Barrett KJ, Davies RJ, Bennett C, Gittens S, Dunlop MG, Faiz O, Fraser A, Garrick V, Johnston PD, Parkes M, Sanderson J, Terry H; IBD guidelines eDelphi consensus group, Gaya DR, Iqbal TH, Taylor SA, Smith M, Brookes M, Hansen R, Hawthorne AB.
Gut. 2019 Dec;68(Suppl 3):s1-s106. - Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn’s disease: a prospective, multicentre, cohort study.
Kennedy NA, Heap GA, Green HD, Hamilton B, Bewshea C, Walker GJ, Thomas A, Nice R, Perry MH, Bouri S, Chanchlani N, Heerasing NM, Hendy P, Lin S, Gaya DR, Cummings JRF, Selinger CP, Lees CW, Hart AL, Parkes M, Sebastian S, Mansfield JC, Irving PM, Lindsay J, Russell RK, McDonald TJ, McGovern D, Goodhand JR, Ahmad T; UK Inflammatory Bowel Disease Pharmacogenetics Study Group.
Lancet Gastroenterol Hepatol. 2019 May;4(5):341-353. - Developing a core outcome set for fistulising perianal Crohn’s disease.
Sahnan K, Tozer PJ, Adegbola SO, Lee MJ, Heywood N, McNair AGK, Hind D, Yassin N, Lobo AJ, Brown SR, Sebastian S, Phillips RKS, Lung PFC, Faiz OD, Crook K, Blackwell S, Verjee A, Hart AL, Fearnhead NS; ENiGMA collaborators.
Gut. 2019 Feb;68(2):226-238. doi: 10.1136/gutjnl-2017-315503. Epub 2018 Feb 3. - Cancer Risk in 2621 Chinese Patients with Inflammatory Bowel Disease: A Population-based Cohort Study.
So J, Tang W, Leung WK, Li M, Lo FH, Wong MTL, Sze ASF, Leung CM, Tsang SWC, Shan EHS, Chan KH, Lam BCY, Hui AJ, Chow WH, Lam TY, Lam V, Lee TW, Lo HHH, Tang CM, Wong CL, Wu JCY, Chan FKL, Sung JJY, Harbord M, Ng SC.
Inflamm Bowel Dis. 2017 Nov;23(11):2061-2068. doi: 10.1097/MIB.0000000000001240. PMID: 28991855 - Third European Evidence-Based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders.
Magro F, Gionchetti P, Eliakim R, Ardizzone S, Armuzzi A, Barreiro-de Acosta M, Burisch J, Gecse KB, Hart AL, Hindryckx P, Langner C, Limdi JK, Pellino G, Zagórowicz E, Raine T, Harbord M, Rieder F; European Crohn’s and Colitis Organisation (ECCO).
J Crohns Colitis. 2017 Feb 2. doi: 10.1093/ecco-jcc/jjx008
- A Systematic Review Assessing Medical Treatment for Rectovaginal and Enterovesical Fistulae in Crohn’s Disease.
Kaimakliotis P, Simillis C, Harbord M, Kontovounisios C, Rasheed S, Tekkis PP.
J Clin Gastroenterol. 2016 Oct;50(9):714-21 - Epidemiology of Inflammatory Bowel Disease from 1981 to 2014: Results from a Territory-Wide Population-Based Registry in Hong Kong.
Ng SC, Leung WK, Shi HY, Li MK, Leung CM, Ng CK, Lo FH, Hui YT, Tsang SW, Chan YK, Loo CK, Chan KH, Hui AJ, Chow WH, Harbord M, Ching JY, Lee M, Chan V, Tang W, Hung IF, Ho J, Lao WC, Wong MT, Sze SF, Shan EH, Lam BC, Tong RW, Mak LY, Wong SH, Wu JC, Chan FK, Sung JJ.
Inflamm Bowel Dis. 2016 Aug;22(8):1954-60 - Low-dose azathioprine is effective in maintaining remission in steroid-dependent ulcerative colitis: results from a territory-wide Chinese population-based IBD registry.
Shi HY, Chan FK, Leung WK, Li MK, Leung CM, Sze SF, Ching JY, Lo FH, Tsang SW, Shan EH, Mak LY, Lam BC, Hui AJ, Chow WH, Wong MT, Hung IF, Hui YT, Chan YK, Chan KH, Loo CK, Ng CK, Lao WC, Harbord M, Wu JC, Sung JJ, Ng SC.
Therap Adv Gastroenterol. 2016 Jul;9(4):449-56
- Why I don’t want to continue practising general medicine and delivering the acute ‘take’
Marcus Harbord
Future Hospital Journal 2016 Vol 3, No 1: 70–1 - Natural History of Elderly-onset Ulcerative Colitis: Results from a Territory-wide Inflammatory Bowel Disease Registry.
Shi HY, Chan FK, Leung WK, Li MK, Leung CM, Sze SF, Ching JY, Lo FH, Tsang SW, Shan EH, Mak LY, Lam BC, Hui AJ, Wong SH, Wong MT, Hung IF, Hui YT, Chan YK, Chan KH, Loo CK, Tong RW, Chow WH, Ng CK, Lao WC, Harbord M, Wu JC, Sung JJ, Ng SC.
J Crohns Colitis. 2016 Feb;10(2):176-85. - The First European Evidence-Based Consensus on Extra-Intestinal Manifestations in Inflammatory Bowel Disease
Marcus Harbord; Vito Annese; Stephan R. Vavricka; et al.
Journal of Crohn’s and Colitis 2016 Mar;10(3):239-54
- Marcus Harbord & Suzanne Pomfret, Nausea and vomiting, Medicine 2013; 41:87-91
- Lotte Dinesen & Marcus Harbord, Acute diarrhoea, Medicine 2013; 104-107
- Editor, CME Gastroenterology
Clin Med 2012; 12(6):572-595 - Hendy P, Patel J, Kordbacheh T, Laskar N and Harbord M
Delays in Discharge: A metropolitan teaching hospital experience
Clin Med 2012; 12(4):320-323 - Patel, K and Harbord, M
Digital dictation and voice transcription software enhances out-patient clinic letter production: a cross-over study.
Frontline Gastroenterology, 2012; 3:162-165 - Siew C. Ng, Susannah Woodrow, Nisha Patel, Javaid Subhani, Marcus Harbord
The Role of Genetic and Environmental Factors In British Twins with Inflammatory Bowel Disease
Inflammatory Bowel Disease, 2012 Apr; 18(4):725-36 - Chowers Y, Sturm A, Sans M, Papadakis K, Gazouli M, Harbord M, Jahnel J, Mantzaris GJ, Meier J, Mottet C, Peyrin- Biroulet L, Allez M.
Report of the ECCO workshop on anti-TNF therapy failures in inflammatory bowel diseases: biological roles and effects of TNF and TNF antagonists.
J Crohns Colitis. 2010 Oct;4(4):367-76. - Hall, M., Clarke S et al, (2010) Annual Evidence Update on Inflammatory Bowel Disease, NLHSpecialist Library for Gastroenterology and Liver Diseases
- Clarke S et al, (2009). Annual Evidence Update on Inflammatory Bowel Disease, NLHSpecialist Library for Gastroenterology and Liver Diseases
- Marcus Harbord, Nausea and vomiting, Medicine 2008; 37:2 115-118
- Chua I, Standish R, Lear S, Harbord M, Eren E, Raeiszadeh M, Workman S, Webster D.
Anti-tumour necrosis factor-alpha therapy for severe enteropathy in patients with common variable immunodeficiency (CVID).
Clin Exp Immunol. 2007 Nov;150(2):306-11 - M Epstein, N Barmania, J Robin, M.W.N.Harbord
Improving the patient journey
Clin Med 2007; 7(4):343-347 - M.W.N.Harbord, D.J.B.Marks, A. Forbes, S.Bloom, R.M.Day, A.W.Segal
Impaired neutrophil chemotaxis in Crohn’s disease relates to reduced production of chemokines and can be augmented by G-CSF
Aliment. Pharmacol. Ther. 2006; 24:651-660 - D.J.B.Marks, M.W.N.Harbord, R.MacAllister, F.Z.Rahman, J.Young, B.Al-Lazikani, W.Lees, M.Novelli, S.Bloom, A.W.Segal
Defective acute inflammation in Crohn’s disease: a clinical investigation
Lancet 2006; 367:668-678 - A.R.Schenkel, T.W.Chew, M.Harbord, W.A.Muller
Different susceptibilities to spontaneous idiopathic pneumonitis in PECAM deficient mouse strains
Experimental and Molecular Pathology, 2006; 81(1):23-30 - N.A. Mitchison, M. Harbord, A. Hankin, J. Roes
Conditional haploinsufficiency of NCF1, a signalling gene with a heterozygous phenotype potentially subject to natural selection
Immunology Letters 2005; 97:63-67 - N. Suraweera, E. Zampeli, P. Rogers, W. Atkin, A. Forbes, M. Harbord, A. Silver
NCF1 (p47phox) and ncf1 pseudogenes are not associated with inflammatory bowel disease
Inflamm Bowel Dis. 2004 Nov;10(6):758-62 - M. Harbord, A. Hankin, S. Bloom, H. Mitchison
Association between p47phox pseudogenes and inflammatory bowel disease
Blood 2003; 101(8):3337 - Plenary poster presentation at the British Society of Gastroenterology 2003 & at the 3rd International Inflammatory Bowel Disease Meeting, Chester, UK (Aliment Pharmacol Ther 2003; 17(4))
- M. Harbord, R. Dawes, H. Barr, M. Giovannini, P. Viens, V. Eysselein, L. Mishra, E. Orenberg, S. Bown
Palliation of dysphagia in advanced esophageal cancer by endoscopic injection of cisplatin/epinephrine injectable gel
Gastrointestinal Endoscopy 2002; 56(5):644-651 - M. Harbord, M. Novelli, B. Canas, D. Power, C. Davis, J. Godovac-Zimmermann, J. Roes, A.W. Segal
Ym1 is a neutrophil granule protein that crystallizes in p47phox deficient mice
J Biol Chem 2002; 277(7): 5468-5475
Presented at the European Society for Clinical Investigation (Eur. J. Clin. Invest. 2001; 31(Suppl. 1): A174) - H. Tiwana, R.S. Natt, R. Benitez-Brito, S. Shah, C. Wilson, S. Bridger, M. Harbord, M. Sarner, A. Ebringer
Correlation between the immune responses to collagens type I, III, IV and V and Klebsiella pneumoniae in patients with Crohn’s disease and ankylosing spondylitis
Rheumatology 2001; 40(1): 15-23 - R. Day, M. Harbord, A. Forbes, A.W.Segal
Cantharidin Blisters : A technique for investigating leukocyte trafficking and cytokine production at sites of inflammation in humans
J. Immunol. Methods 2001; 257: 213-220 - M. Harbord, S Ivanova, N Akhtar, Y Gupta
Waldenström macroglobulinaemia presenting as bleeding diathesis with paradoxical coagulation of blood samples
J. Acc. & Emer. Med. 1998; 15(5): 331 - K. Besherdas, A. Leahy, I. Mason, M. Harbord, O. Epstein
The effect of cisapride on dyspepsia symptoms and the electrogastrogram in patients with non-ulcer dyspepsia
Aliment. Pharmacol. Ther. 1998; 12: 755-759
Electronic Media
- Owen Epstein & Marcus Harbord
Answers in Gastroenterology, Educational CD. Published by Answers in Medicine, 2008 - M. Harbord, I. Mason, J. Bowles, J. Linehan, O. Epstein
How to use suppositories, foams and enemas in colitis
Gut 1999; 44(1): 576V
(Second prize, B.S.G. video competition 1999) - M. Harbord, G. Webster, J. Linehan, O. Epstein
Interactive Gastro-Endoscopy CD-Rom
Gut 1999; 44(1): 579V
(CD-ROM Special Prize, B.S.G. video competition 1999)